BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Debiopharm Acquires Global Rights for Novo Nordisk's USP1 Inhibitor Development.

Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow's standard-of-care treatments to cure can...

March 02, 2023 | News

GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service

GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, announced the expansion of its Singapor...

March 01, 2023 | News

SK bioscience’s Shingles Vaccine Secures the Highest Market Share in South Korea

‘SKYZoster®, ' the world second developed shingles vaccine secures 54% of the South Korean market share With proven immunogenicity and s...

February 28, 2023 | News

Merck Unveils Promising Four-Year Safety and Efficacy Data for Evobrutinib, Investigational BTK Inhibitor in RMS

Data from the ongoing Phase II extension showed treatment benefits of evobrutinib were maintained over four years and remained consistent with the effica...

February 27, 2023 | News

Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences

Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the f...

February 21, 2023 | News

Celltrion and LISCure Biosciences to develop novel microbiome treatment for Parkinson's disease

Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease U...

February 21, 2023 | News

Bio-techne and Cell Signaling Technology Announce Partnership to Validate Simple Western Antibodies

Simple Western systems from ProteinSimple, a Bio-Techne brand, are the only fully automated western blotting solutions for protein detection and ch...

February 16, 2023 | News

Merck announced findings of a new analysis of long-term follow-up data from the Phase III JAVELIN Bladder 100 trial

Long-term follow-up of the Phase III JAVELIN Bladder 100 study demonstrated median overall survival from start of chemotherapy of 29.7 months among patie...

February 16, 2023 | News

Inventia Life Science collaborates with MSD to develop 3D advanced cell models

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...

February 16, 2023 | News

Biotage strengthens its position as a global chromatography leader with the transformative acquisition of Astrea Bioseparations

Biotage has entered into an agreement to acquire Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a global li...

February 15, 2023 | News

Vir Biotechnology Announces Amended Collaboration Agreement with GSK

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the research collaboration agreement established with GSK in 2020 has been amended to reflect th...

February 14, 2023 | News

Thermo Fisher Scientific Launches TrueMark STI Select Panel

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its Applied Biosystems TrueMark STI Select Panel, a polymerase...

February 08, 2023 | News

Thermo Fisher Scientific launches Cell Therapy Collaboration Center Program in Singapore to accelerate therapy development across Asia Pacific

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of its new Cell Therapy Collaboration Center Program in ...

February 07, 2023 | News

GenScript is increasing its capacity for producing cGMP sgRNA and non-viral DNA payloads in order to keep project wait times to a minimum.

How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...

February 01, 2023 | Influencers

Stay Connected